Drugs / AZD5658
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01176097 Comparator | Jul 2010 → Feb 2011 | type 2 diabetes mellitus | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD5658 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01176097 ↗ |
| Route | Oral | “ascending single oral doses” NCT01176097 ↗ |